Citadel Advisors
VMD icon

Citadel Advisors’s Viemed Healthcare VMD Stock Holding History

Citadel Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Sell
11,730
-48,753
-81% -$406K ﹤0.01% 11941
2025
Q4 		$449K Sell
60,483
-48,106
-44% -$330K ﹤0.01% 9294
2025
Q3 		$737K Sell
108,589
-36,397
-25% -$246K ﹤0.01% 8222
2025
Q2 		$1M Buy
144,986
+120,119
+483% +$815K ﹤0.01% 7077
2025
Q1 		$181K Sell
24,867
-21,682
-47% -$170K ﹤0.01% 10589
2024
Q4 		$373K Buy
46,549
+11,388
+32% +$98.8K ﹤0.01% 9203
2024
Q3 		$258K Sell
35,161
-37,039
-51% -$265K ﹤0.01% 9611
2024
Q2 		$473K Buy
72,200
+57,175
+381% +$431K ﹤0.01% 8163
2024
Q1 		$142K Buy
15,025
+301
+2% +$2.58K ﹤0.01% 10848
2023
Q4 		$116K Sell
14,724
-42,454
-74% -$308K ﹤0.01% 10749
2023
Q3 		$385K Buy
57,178
+16,005
+39% +$131K ﹤0.01% 8638
2023
Q2 		$403K Buy
41,173
+14,606
+55% +$148K ﹤0.01% 8401
2023
Q1 		$257K Sell
26,567
-10,901
-29% -$95K ﹤0.01% 9702
2022
Q4 		$283K Sell
37,468
-54,321
-59% -$368K ﹤0.01% 9440
2022
Q3 		$551K Sell
91,789
-96,178
-51% -$617K ﹤0.01% 8249
2022
Q2 		$1.01M Buy
187,967
+52,247
+38% +$282K ﹤0.01% 6989
2022
Q1 		$676K Buy
135,720
+31,614
+30% +$147K ﹤0.01% 8654
2021
Q4 		$543K Buy
104,106
+24,715
+31% +$138K ﹤0.01% 9495
2021
Q3 		$441K Sell
79,391
-15,574
-16% -$101K ﹤0.01% 10186
2021
Q2 		$679K Sell
94,965
-4,316
-4% -$37.4K ﹤0.01% 9312
2021
Q1 		$1M Sell
99,281
-6,357
-6% -$59.8K ﹤0.01% 8098
2020
Q4 		$819K Buy
105,638
+88,017
+500% +$774K ﹤0.01% 7212
2020
Q3 		$153K Buy
+17,621
New +$178K ﹤0.01% 8991

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Citadel Advisors's VMD Position: Q1 2026 in Review

Citadel Advisors reduced its Viemed Healthcare (VMD) stake by 81% in Q1 2026, selling an estimated $406K and leaving 11,730 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #11941.

Citadel Advisors first reported a position in VMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.01M in Q2 2022. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Citadel Advisors held 11,730 shares of Viemed Healthcare worth $108K as of Q1 2026.
  • Citadel Advisors sold 48,753 Viemed Healthcare shares in Q1 2026, an estimated $406K.
  • Viemed Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11941 holding.
  • Citadel Advisors first reported a position in Viemed Healthcare in Q3 2020 and has held it in 23 quarters since.
  • Citadel Advisors's Viemed Healthcare position peaked at $1.01M in Q2 2022.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.